Numerous pharmacological agents have been tested in order to reduce acute thrombosis and the hyperproliferative cellular response, and drug eluting stents-using the stent as a platform for
local drug delivery-are now considered a significant breakthrough in interventional cardiology. This book discusses threatened vessel closure and restenosis, acute thrombosis, hyperproliferative cellular response, stents and local drug delivery. The contributors share their expertise on all aspects of the field, including remarks on results from preclinical and clinical studies, and alternative methods of molecular delivery to the
vessel wall.
Cardiologists, pharmacologists, and cardiac surgeons will find…
